Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors

Gene Therapy

Volumn 12, Issue 5, 2005, Pages 395-406

  Wieser, C ^a   Stumpf, D ^a   Grillhosl C ^a   Lengenfelder, D ^a   Gay, S ^b   Fleckenstein, B ^a   Ensser, A ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

GeneSwitch; Herpesvirus saimiri; Rheumatoid arthritis; Vector

Indexed keywords

ANTIGESTAGEN; GROWTH HORMONE; HERPESVIRUS VECTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; MIFEPRISTONE; PROGESTERONE; STROMELYSIN;

ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; ENHANCER REGION; EPISOME; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS RECOMBINANT;

ARTHRITIS, RHEUMATOID; CELL CULTURE TECHNIQUES; CYTOKINES; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 2, SAIMIRIINE; HORMONE ANTAGONISTS; HUMANS; INTERLEUKIN-10; MIFEPRISTONE; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSDUCTION, GENETIC;

BOVINAE; CUCUMBER MOSAIC VIRUS; HERPESVIRIDAE; PRIMATES; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

EID: 15444380846     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302424     Document Type: Article

References (47)

1. Fleckenstein B, Desrosiers RC. Herpesvirus saimiri and herpesvirus ateles. In: Roizman B (ed). The Herpesviruses, Vol. 1. Plenum Press: New York, London, 1982, pp 253-332.
2. Biesinger B, Trimble JJ, Desrosiers RC, Fleckenstein B. The divergence between two oncogenic herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 1990; 176: 505-514.
3. Medveczky MM et al. Herpesvirus saimiri strains from three DNA subgroups have different oncogenic potentials in New Zealand white rabbits. J Virol 1989; 63: 3601-3611.
4. Medveczky P, Szomolanyi E, Desrosiers RC, Mulder C. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol 1984; 52: 938-944.
5. Biesinger B et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 1992; 89: 3116-3119.
6. Fickenscher H et al. Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes. J Virol 1996; 70: 6012-6019.
7. Ensser A, Thurau M, Wittmann S, Fickenscher H. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 2003; 314: 471-487.
8. Duboise SM et al. STP and Tip are essential for herpesvirus saimiri oncogenicity. J Virol 1998; 72: 1308-1313.
9. Ensser A, Thurau M, Wittmann S, Fickenscher H. The primary structure of the herpesvirus saimiri strain C488 genome. Virology 2003; 314: 471-487.
10. Desrosiers RC et al. Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol Cell Biol 1985; 5 2796-2803.
11. Desrosiers RC, Burghoff RL, Bakker A, Kamine J. Construction of replication-competent herpesvirus saimiri deletion mutants. J Virol 1984; 49: 343-348.
12. Simmer B et al. Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines. J Gen Virol 1991; 72: 1953-1958.
13. Grassmann R, Fleckenstein B. Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line. J Virol 1989; 63: 1818-1821.
14. Frolova-Jones EA et al. Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J Hematother Stem Cell Res 2000; 9: 573-581.
15. Stevenson AJ et al. Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells. Br J Cancer 2000; 83: 329-332.
16. Stevenson AJ et al. Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro. Gene Therapy 2000; 7: 464-471.
17. Stevenson AJ et al. A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy. Cancer Gene Ther 2000; 7: 1077-1085.
18. Schmitt I et al. Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol 1998; 72: 633-640.
19. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
20. Rivera VM et al. A humanized system for pharmacologic control of gene expression [see comments]. Nat Med 1996; 2: 1028-1032.
21. Christopherson KS, Mark MR, Bajaj V, Godowski PJ. Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci USA 1992; 89: 6314-6318.
22. Wang Y, O'Malley-BWJ, Tsai SY, O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 1994; 91 8180-8184.
23. Schäfer A et al. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J Virol 2003; 77: 5911-5925.
24. Burcin MM et al. Adenovirus-mediated regulable target gene expression in vivo. Proc Natl Acad Sci USA 1999; 96: 355-360.
25. Wang XJ et al. Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci USA 1999; 96: 8483-8488.
26. Tsai SY et al. A novel RU486 inducible system for the activation and repression of genes. Adv Drug Deliv Rev 1998; 30 23-31.
27. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358: 903-911.
28. Muller-Ladner U et al. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 1997; 158: 3492-3498.
29. Müller-Ladner U et al. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 1999; 42: 490-497.
30. Neumann E et al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Therapy 2002; 9: 1508-1519.
31. Ensser A, Pfinder A, Müller-Fleckenstein I, Fleckenstein B. The URNA genes of herpesvirus saimiri (strain C488) are dispensable for transformation of human T cells in vitro. J Virol 1999; 73 10551-10555.
32. Tomkinson B et al. Epstein-Barr virus recombinants from overlapping cosmid fragments. J Virol 1993; 67: 7298-7306.
33. Fu S, Deisseroth AB. Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors. Hum Gene Ther 1997; 8: 1321-1330.
34. Daniel MD, Silva D, Ma N. Establishment of owl monkey kidney 210 cell line for virological studies. In Vitro 1976; 12: 290.
35. Muller-Ladner U et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607-1615.
36. Stevenson AJ et al. Assessment of Herpesvirus saimiri as a potential human gene therapy vector. J Med Virol 1999; 57 269-277.
37. Grassmann R et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci USA 1989; 86: 3351-3355.
38. Vegeto E et al. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 1992; 69: 703-713.
39. Cassatella MA et al. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994; 179: 1695-1699.
40. Kline JN, Fisher PA, Monick MM, Hunninghake GW. Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. Am J Physiol 1995; 269 (Part 1): L92-L98.
41. Denison FC et al. The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. Mol Hum Reprod 2000; 6: 541-548.
42. DiBattista JA et al. Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes. J Clin Endocrinol Metab 1991; 72 316-326.
43. Sarkar NN. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. Eur J Obstet Gynecol Reprod Biol 2002; 101: 113-120.
44. Xu ZL, Mizuguchi H, Mayumi T, Hayakawa T. Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems. Gene 2003; 309: 145-151.
45. Hoggarth JH, Jones E, Ensser A, Meredith DM. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector. Cancer Gene Ther 2004; 11: 613-624.
46. Mengshol JA, Mix KS, Brinckerhoff CE. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark? Arthritis Rheum 2002; 46: 13-20.
47. Robbins PD, Evans CH, Chernajovsky Y. Gene therapy for arthritis. Gene Therapy 2003; 10: 902-911.